Standard BioTools Inc., was founded in California on May 19, 1999. The company's established product portfolio includes necessary, standardized next-generation solutions designed to help biomedical researchers develop better therapies faster. The company provides a variety of instruments, consumables and services that generate high-quality data in early detection, translational and clinical research. With advanced technologies in proteomics and genomics, the company enables scientists to gain deeper biological insights, accelerate discoveries, and drive improved health outcomes in different therapeutic areas including immunology, oncology, neuroscience, cardiometabolic diseases, etc.
